Cargando…
A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer
BACKGROUND: The acidic microenvironment of cancer can promote tumor metastasis and drug resistance. Acidic tumor microenvironment-targeted therapy is currently an important means for treating tumors, inhibiting metastasis, and overcoming drug resistance. In this study, a dual pH-responsive DOX-encap...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121622/ https://www.ncbi.nlm.nih.gov/pubmed/34007173 http://dx.doi.org/10.2147/IJN.S303874 |
_version_ | 1783692398567620608 |
---|---|
author | Zhai, Luoping Luo, Chuangwei Gao, Hannan Du, Shuaifan Shi, Jiyun Wang, Fan |
author_facet | Zhai, Luoping Luo, Chuangwei Gao, Hannan Du, Shuaifan Shi, Jiyun Wang, Fan |
author_sort | Zhai, Luoping |
collection | PubMed |
description | BACKGROUND: The acidic microenvironment of cancer can promote tumor metastasis and drug resistance. Acidic tumor microenvironment-targeted therapy is currently an important means for treating tumors, inhibiting metastasis, and overcoming drug resistance. In this study, a dual pH-responsive DOX-encapsulated liposome (DOPE-DVar7-lip@DOX) was designed and fabricated for targeting the acidic tumor microenvironment. On the one hand, the response of acid-sensitive peptide (DVar7) to the acidic tumor microenvironment increased the uptake of liposomes in tumors and prolonged the retention time; on the other hand, the response of acid-sensitive phospholipid (DOPE) to the acidic tumor microenvironment improved the controlled release of DOX in tumors. METHODS: The acid-sensitive peptide DVar7 modified liposomes can be obtained by simple incubation of DSPE-DVar7 with DOX-loaded DOPE liposomes (DOPE-lip@DOX). The tumor targeting of the dual pH-responsive liposome was investigated in vitro and in vivo by near-infrared fluorescence imaging. The tumor therapeutic efficacy of DOPE-DVar7-lip@DOX was evaluated in breast cancer mouse model using the traditional liposome as a control. Moreover, we regulated the tumor microenvironment acidity by injecting glucose to further enhance the therapeutic efficacy of cancer. RESULTS: DVar7 can allosterically insert into the tumor cell membrane in the acidic tumor microenvironment to enhance the tumor uptake of liposomes and prolong the retention time of liposomes in tumor. In addition, the therapeutic efficacy of pH-responsive liposomes can be further enhanced by glucose injection regulating the acidity of tumor microenvironment. DISCUSSION: DVar7 modified acid-sensitive nanocarriers combined with acidity regulation have great potential to improve drug resistance in clinical practice, thus improving the response rate and therapeutic effect of chemotherapy. |
format | Online Article Text |
id | pubmed-8121622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-81216222021-05-17 A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer Zhai, Luoping Luo, Chuangwei Gao, Hannan Du, Shuaifan Shi, Jiyun Wang, Fan Int J Nanomedicine Original Research BACKGROUND: The acidic microenvironment of cancer can promote tumor metastasis and drug resistance. Acidic tumor microenvironment-targeted therapy is currently an important means for treating tumors, inhibiting metastasis, and overcoming drug resistance. In this study, a dual pH-responsive DOX-encapsulated liposome (DOPE-DVar7-lip@DOX) was designed and fabricated for targeting the acidic tumor microenvironment. On the one hand, the response of acid-sensitive peptide (DVar7) to the acidic tumor microenvironment increased the uptake of liposomes in tumors and prolonged the retention time; on the other hand, the response of acid-sensitive phospholipid (DOPE) to the acidic tumor microenvironment improved the controlled release of DOX in tumors. METHODS: The acid-sensitive peptide DVar7 modified liposomes can be obtained by simple incubation of DSPE-DVar7 with DOX-loaded DOPE liposomes (DOPE-lip@DOX). The tumor targeting of the dual pH-responsive liposome was investigated in vitro and in vivo by near-infrared fluorescence imaging. The tumor therapeutic efficacy of DOPE-DVar7-lip@DOX was evaluated in breast cancer mouse model using the traditional liposome as a control. Moreover, we regulated the tumor microenvironment acidity by injecting glucose to further enhance the therapeutic efficacy of cancer. RESULTS: DVar7 can allosterically insert into the tumor cell membrane in the acidic tumor microenvironment to enhance the tumor uptake of liposomes and prolong the retention time of liposomes in tumor. In addition, the therapeutic efficacy of pH-responsive liposomes can be further enhanced by glucose injection regulating the acidity of tumor microenvironment. DISCUSSION: DVar7 modified acid-sensitive nanocarriers combined with acidity regulation have great potential to improve drug resistance in clinical practice, thus improving the response rate and therapeutic effect of chemotherapy. Dove 2021-05-10 /pmc/articles/PMC8121622/ /pubmed/34007173 http://dx.doi.org/10.2147/IJN.S303874 Text en © 2021 Zhai et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhai, Luoping Luo, Chuangwei Gao, Hannan Du, Shuaifan Shi, Jiyun Wang, Fan A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer |
title | A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer |
title_full | A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer |
title_fullStr | A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer |
title_full_unstemmed | A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer |
title_short | A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer |
title_sort | dual ph-responsive dox-encapsulated liposome combined with glucose administration enhanced therapeutic efficacy of chemotherapy for cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121622/ https://www.ncbi.nlm.nih.gov/pubmed/34007173 http://dx.doi.org/10.2147/IJN.S303874 |
work_keys_str_mv | AT zhailuoping adualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT luochuangwei adualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT gaohannan adualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT dushuaifan adualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT shijiyun adualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT wangfan adualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT zhailuoping dualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT luochuangwei dualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT gaohannan dualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT dushuaifan dualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT shijiyun dualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer AT wangfan dualphresponsivedoxencapsulatedliposomecombinedwithglucoseadministrationenhancedtherapeuticefficacyofchemotherapyforcancer |